MAPT and tauopathy: These findings highlight the critical importance of dissecting the composition of disease-specific and shared tau-associated proteins for the development of therapeutic strategies that target mechanisms of tau aggregation, as well as development of biomarkers for differential diagnosis and disease-specific early detection of tauopathies [28–34].